CBIZ, Inc.
CBZ NYSE Services-Business Services, Nec Financials FY2016–FY2025
Last close · Oct 23, 2026
$54.94
0.1%What CBIZ, Inc. does
No business description yet.
- Legal name
- CBIZ, Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Feb 26, 2026
- Accession · CIK
- 0000944148-26-000038
0000944148
Revenue and margins
CBIZ, Inc. had $2.8B of revenue in fiscal 2025, up 52.1% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 10.4% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $176M in fiscal 2025, 6.4% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
CBIZ, Inc. returned $160M to shareholders in fiscal 2025, 91% of free cash flow. The diluted share count rose 20.1%.
Balance sheet
Cash, debt and the ratios that show how comfortably CBIZ, Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $2.0M | $4.7M | $8.1M | $13.8M | $18.3M |
| Debt incl. finance leases | $155M | $264M | $311M | $1.4B | $1.5B |
| Net debt / EBITDA | 1.5x | 1.3x | 1.5x | 11.4x | 4.3x |
| Debt / equity | 0.2x | 0.4x | 0.4x | 0.8x | 0.8x |
| Interest coverage | 18.8x | 20.9x | 8.2x | 2.1x | 2.2x |
| Current ratio | 1.1x | 1.1x | 1.2x | 1.2x | 1.2x |
| Quick ratio | 1.1x | 1.1x | 1.2x | 1.2x | 1.2x |
| Total assets | $1.6B | $1.9B | $2.0B | $4.5B | $4.4B |
| Total liabilities | $923M | $1.2B | $1.3B | $2.7B | $2.6B |
| Shareholders' equity | $705M | $713M | $792M | $1.8B | $1.8B |
| Net debt (− = net cash) | $153M | $259M | $303M | $1.4B | $1.4B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. “Plan” marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Cash from operations is positive | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Return on assets rose | — | ✓ | ✓ | ✕ | ✓ | ✕ | ✓ | ✓ | ✕ | ✓ |
| Cash from operations exceeds net income | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Debt fell relative to assets | — | ✓ | ✓ | ✓ | ✓ | ✕ | ✕ | ✕ | ✕ | ✕ |
| Current ratio rose | — | ✓ | ✕ | ✕ | ✕ | ✕ | ✓ | ✓ | ✕ | ✓ |
| Share count didn't rise | — | ✕ | ✕ | ✓ | ✓ | ✓ | ✓ | ✓ | ✕ | ✕ |
| Gross margin rose | — | ✕ | ✓ | ✕ | ✓ | ✓ | ✓ | ✕ | ✕ | ✓ |
| Revenue rose relative to assets | — | ✓ | ✓ | ✕ | ✕ | ✓ | ✓ | ✓ | ✕ | ✓ |
| F-score | — / 3 | 7 / 9 | 7 / 9 | 5 / 9 | 7 / 9 | 6 / 9 | 8 / 9 | 7 / 9 | 3 / 9 | 7 / 9 |
| Accruals ratio | −3.0% | −2.3% | −3.7% | −2.1% | −4.7% | −3.8% | −1.2% | −1.7% | −2.5% | −1.7% |
| Altman Z'' | 2.64 | 2.84 | 3.28 | 2.86 | 2.77 | 2.47 | 2.71 | 2.89 | 1.65 | 2.05 |
10 years of figures
Amounts in USD. Hover a ratio’s name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $800M | $855M | $922M | $948M | $964M | $1.1B | $1.4B | $1.6B | $1.8B | $2.8B |
| Gross profit | $102M | $99.8M | $132M | $125M | $139M | $159M | $223M | $223M | $182M | $355M |
| Operating income | $65.8M | $66.5M | $92.5M | $80.5M | $92.5M | $72.7M | $168M | $165M | $73.7M | $234M |
| Interest expense | $6.6M | $6.7M | $6.6M | $5.8M | $5.0M | $3.9M | $8.0M | $20.1M | $34.4M | $107M |
| Pretax income | $67.0M | $74.3M | $79.8M | $92.9M | $103M | $93.0M | $141M | $166M | $57.8M | $161M |
| Income tax | $26.4M | $23.3M | $18.3M | $21.8M | $25.1M | $22.1M | $36.1M | $45.3M | $16.8M | $45.4M |
| Net income | $40.1M | $50.4M | $61.6M | $70.7M | $78.3M | $70.9M | $105M | $121M | $41.0M | $115M |
| Diluted EPS | $0.75 | $0.91 | $1.09 | $1.26 | $1.41 | $1.32 | $2.01 | $2.39 | $0.78 | $1.83 |
| Diluted shares | 0.05B | 0.06B | 0.06B | 0.06B | 0.06B | 0.05B | 0.05B | 0.05B | 0.05B | 0.06B |
| Cash flow | ||||||||||
| Cash from operations | $74.1M | $77.0M | $105M | $98.2M | $147M | $131M | $126M | $154M | $124M | $192M |
| Capital expenditure | $4.1M | $11.9M | $14.6M | $13.9M | $11.6M | $9.0M | $8.6M | $23.1M | $12.9M | $17.0M |
| Free cash flow | $69.9M | $65.1M | $90.6M | $84.3M | $135M | $122M | $117M | $130M | $111M | $176M |
| Depreciation and amortization | $22.1M | $23.1M | $23.7M | $22.3M | $23.1M | $27.1M | $32.9M | $36.3M | $48.1M | $98.3M |
| Stock-based compensation | $5.7M | $5.7M | $6.9M | $7.3M | $8.9M | $11.4M | $14.7M | $12.3M | $13.8M | $26.0M |
| Acquisitions | $5.7M | $28.1M | $29.1M | $11.7M | $71.4M | $66.7M | $79.1M | $53.1M | $1.1B | $1.6M |
| Share buybacks | $9.1M | $19.7M | $17.5M | $27.2M | $56.5M | $97.5M | $123M | $65.4M | $0.0M | $160M |
| Dividends and buybacks | $9.1M | $19.7M | $17.5M | $27.2M | $56.5M | $97.5M | $123M | $65.4M | $0.0M | $160M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $3.5M | $0.4M | $0.6M | $0.6M | $4.7M | $2.0M | $4.7M | $8.1M | $13.8M | $18.3M |
| Total debt | $190M | $178M | $134M | $104M | $107M | $155M | $264M | $311M | $1.4B | $1.5B |
| Current assets | $442M | $448M | $424M | $456M | $436M | $452M | $568M | $613M | $836M | $899M |
| Current liabilities | $339M | $334M | $321M | $366M | $378M | $423M | $512M | $512M | $706M | $736M |
| Property and equipment, net | $19.5M | $26.1M | $34.2M | $39.4M | $41.3M | $43.4M | $45.2M | $57.0M | $88.2M | $81.2M |
| Goodwill | $487M | $528M | $564M | $588M | $683M | $741M | $820M | $865M | $2.3B | $2.3B |
| Total assets | $1.1B | $1.2B | $1.2B | $1.4B | $1.5B | $1.6B | $1.9B | $2.0B | $4.5B | $4.4B |
| Total liabilities | $639M | $645M | $589M | $742M | $811M | $923M | $1.2B | $1.3B | $2.7B | $2.6B |
| Shareholders' equity | $480M | $531M | $594M | $659M | $703M | $705M | $713M | $792M | $1.8B | $1.8B |
| Margins | ||||||||||
| Gross margin | 12.8% | 11.7% | 14.3% | 13.2% | 14.4% | 14.4% | 15.8% | 14.0% | 10.1% | 12.9% |
| Operating margin | 8.2% | 7.8% | 10.0% | 8.5% | 9.6% | 6.6% | 11.9% | 10.4% | 4.1% | 8.5% |
| EBITDA margin | 11.0% | 10.5% | 12.6% | 10.8% | 12.0% | 9.0% | 14.3% | 12.7% | 6.7% | 12.0% |
| Net margin | 5.0% | 5.9% | 6.7% | 7.5% | 8.1% | 6.4% | 7.5% | 7.6% | 2.3% | 4.2% |
| FCF margin | 8.7% | 7.6% | 9.8% | 8.9% | 14.0% | 11.1% | 8.3% | 8.2% | 6.1% | 6.4% |
| Returns | ||||||||||
| Return on capital | 6.4% | 6.4% | 9.8% | 8.1% | 8.7% | 6.5% | 12.9% | 11.0% | 1.7% | 5.2% |
| Return on capital employed | 8.4% | 7.9% | 10.7% | 7.8% | 8.1% | 6.0% | 12.3% | 10.8% | 2.0% | 6.4% |
| Return on equity | 8.3% | 10.0% | 11.0% | 11.3% | 11.5% | 10.1% | 14.9% | 16.1% | 3.2% | 6.5% |
| Return on assets | 3.6% | 4.4% | 5.2% | 5.5% | 5.4% | 4.5% | 6.0% | 6.2% | 1.3% | 2.6% |
| Return on tangible equity | — | 2,052.0% | 209.7% | 99.6% | 400.8% | — | — | — | — | — |
| Growth | ||||||||||
| Revenue growth | — | 6.9% | 7.8% | 2.9% | 1.6% | 14.6% | 27.8% | 12.7% | 14.0% | 52.1% |
| Net income growth | — | 25.7% | 22.2% | 14.9% | 10.7% | −9.5% | 48.6% | 14.8% | −66.1% | 181.3% |
| EPS growth | — | 21.3% | 19.8% | 15.6% | 11.9% | −6.4% | 52.3% | 18.9% | −67.4% | 134.6% |
| FCF growth | — | −6.8% | 39.1% | −7.0% | 60.4% | −9.7% | −3.8% | 11.0% | −15.1% | 58.4% |
| Share count change | — | 4.1% | 1.4% | −1.0% | −1.0% | −3.0% | −2.5% | −3.5% | 4.2% | 20.1% |
| Financial health | ||||||||||
| Net debt / EBITDA | 2.1x | 2.0x | 1.1x | 1.0x | 0.9x | 1.5x | 1.3x | 1.5x | 11.4x | 4.3x |
| Debt / equity | 0.4x | 0.3x | 0.2x | 0.2x | 0.2x | 0.2x | 0.4x | 0.4x | 0.8x | 0.8x |
| Interest coverage | 10.0x | 10.0x | 13.9x | 14.0x | 18.6x | 18.8x | 20.9x | 8.2x | 2.1x | 2.2x |
| Current ratio | 1.3x | 1.3x | 1.3x | 1.2x | 1.2x | 1.1x | 1.1x | 1.2x | 1.2x | 1.2x |
| Quick ratio | 1.3x | 1.3x | 1.3x | 1.2x | 1.2x | 1.1x | 1.1x | 1.2x | 1.2x | 1.2x |
| Capital allocation | ||||||||||
| Capex / revenue | 0.5% | 1.4% | 1.6% | 1.5% | 1.2% | 0.8% | 0.6% | 1.4% | 0.7% | 0.6% |
| Stock comp / revenue | 0.7% | 0.7% | 0.7% | 0.8% | 0.9% | 1.0% | 1.0% | 0.8% | 0.8% | 0.9% |
| Payouts / FCF | 13.1% | 30.3% | 19.3% | 32.2% | 41.8% | 79.8% | 104.3% | 50.1% | 0.0% | 91.2% |
| Quality scores | ||||||||||
| Piotroski F-score | — | 7.0 | 7.0 | 5.0 | 7.0 | 6.0 | 8.0 | 7.0 | 3.0 | 7.0 |
| Altman Z'' | 2.6 | 2.8 | 3.3 | 2.9 | 2.8 | 2.5 | 2.7 | 2.9 | 1.6 | 2.0 |
| Accruals ratio | −3.0% | −2.3% | −3.7% | −2.1% | −4.7% | −3.8% | −1.2% | −1.7% | −2.5% | −1.7% |
Source: SEC EDGAR XBRL filings (CIK 0000944148). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.
